Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
The mechanism of action for AOD 9604 involves stimulating fat breakdown and fat oxidation in adipose tissue, supporting research into its potential as a treatment for obesity and metabolic disorders
Thymosin alpha1: A clinically active biological response modifier
Clinical trials specifically using the arginate formulation would provide human pharmacokinetic data and efficacy endpoints
A sudden loss of strength, deformity, or inability to bear weight may need imaging or urgent injury evaluation
Since TB-500 protocols mean drawing multiple doses from the same vial over several weeks, BWI keeps the solution safe for those full 28 days in the fridge
